Exhibit 10.6
FISCAL 2017 EXECUTIVE OFFICER BONUS PLAN AND EQUITY COMPENSATION

Bonus Plan

For the twelve month period ending June 30, 2017, each executive officer of
Cardiovascular Systems, Inc. (the “Company”) is eligible to receive cash
incentive compensation pursuant to the Fiscal 2017 Executive Officer Bonus Plan
(the “Bonus Plan”) as follows:

Revenue and Adjusted EBITDA Goals

Receipt of cash incentive compensation for fiscal 2017 is based on the Company’s
achievement of revenue and adjusted EBITDA financial goals for fiscal 2017.
Adjusted EBITDA is defined as EBITDA with stock compensation added back into the
calculation, in addition to an add-back of depreciation and amortization. Target
bonus amounts are weighted 50% for the revenue goal and 50% for the adjusted
EBITDA goal. Target bonus levels as a percentage of base salary are 115% for the
Chairman, President and Chief Executive Officer, 90% for the Chief Operating
Officer, 75% for the Chief Financial Officer, 65% for the Chief Talent Officer
and Senior Vice President of Manufacturing and Operations, and 50% for the
General Counsel and Corporate Secretary. Depending upon the Company’s
performance against the goals, participants are eligible to earn 50% to 200% of
each of the adjusted EBITDA and revenue portions of their target bonus amount.
The Bonus Plan criteria are the same for all of the executive officers.

Equity Compensation

Additionally, each executive officer of the Company received the following
grants of restricted stock on August 8, 2016, except for Mr. Ward, who received
his grant on August 17, 2016 following his appointment as the Company's
President and Chief Executive Officer:
Name/Title
  
Time-Based
 
Shareholder Return
Scott R. Ward
Chairman, President and Chief Executive Officer
  
33,991

 
118,814

Laurence L. Betterley
Chief Financial Officer
  
16,084

 
48,251

Kevin Kenny
Chief Operating Officer
 
16,374

 
49,120

Laura Gillund
Chief Talent Officer
  
7,152

 
21,455

Paul Koehn
Senior Vice President of Manufacturing and Operations
  
7,961

 
23,881

Alexander Rosenstein
General Counsel and Corporate Secretary
 
6,428

 
19,283

The amount of restricted stock granted to each executive officer is based upon
the target equity grant for each executive officer divided by the closing price
per share of the Company’s common stock on the date of grant; however, the
restricted stock grants that vest based on total shareholder return provide the
executive officer the opportunity to earn up to 200% of the target number of
shares if performance goals are satisfied, and the grants set forth above
represent such maximum amount and any shares not earned will be forfeited upon
confirmation of performance achievement. Target equity grants as a percentage of
base salary are 350% for the Chairman, President and Chief Executive Officer,
225% for the Chief Financial Officer, 200% for the Chief Operating Officer, and
125% for the other executive officers. The restricted stock grants under the
column above titled (i) “Time-Based” will vest in equal installments of 1/3 on
each of August 13, 2017, 2018 and 2019; and (ii) “Shareholder Return” will vest
based on the Company’s total shareholder return relative to total shareholder
return of the Company's peer group, as measured by the closing prices of the
stock of the Company and the peer group members for the 90 trading days
preceding July 1, 2016 compared to the closing prices of the stock of the
Company and the peer group members for the 90 trading days preceding July 1,
2019. Vesting of the performance-vesting shares will be determined on the date
that the Company's Annual Report on Form 10-K for the fiscal year ending June
30, 2019 is filed.